These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 31658043

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P.
    Oncotarget; 2017 May 23; 8(21):34468-34480. PubMed ID: 28380431
    [Abstract] [Full Text] [Related]

  • 25. Plasma microRNA signature of patients with IgA nephropathy.
    Wu J, Zhang H, Wang W, Zhu M, Qi LW, Wang T, Cheng W, Zhu J, Shan X, Huang Z, Zhang L, Chen Y, Sun B, Zhao X, Qian J, Zhu W, Zhou X, Xing C.
    Gene; 2018 Apr 05; 649():80-86. PubMed ID: 29459010
    [Abstract] [Full Text] [Related]

  • 26. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
    Chiam K, Mayne GC, Wang T, Watson DI, Irvine TS, Bright T, Smith LT, Ball IA, Bowen JM, Keefe DM, Thompson SK, Hussey DJ.
    World J Gastroenterol; 2020 May 28; 26(20):2570-2583. PubMed ID: 32523312
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J, Yan F, Zhao Q, Zhan F, Wang R, Wang L, Zhang Y, Huang X.
    Sci Rep; 2017 Jun 23; 7(1):4150. PubMed ID: 28646161
    [Abstract] [Full Text] [Related]

  • 30. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
    Wang W, Yin Y, Shan X, Zhou X, Liu P, Cao Q, Zhu D, Zhang J, Zhu W.
    Am J Med Sci; 2019 Oct 23; 358(4):256-267. PubMed ID: 31353030
    [Abstract] [Full Text] [Related]

  • 31. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y, Zhang Y, Yin Y, Li S.
    Pathol Res Pract; 2019 Aug 23; 215(8):152466. PubMed ID: 31146974
    [Abstract] [Full Text] [Related]

  • 32. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
    Zhang Y, Zhang D, Wang F, Xu D, Guo Y, Cui W.
    Sci Rep; 2015 Dec 14; 5():17942. PubMed ID: 26656154
    [Abstract] [Full Text] [Related]

  • 33. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X, Jiang X, Gu D, Zhang Y, Kong SK, Jiang C, Xie W.
    Int J Med Sci; 2016 Dec 14; 13(3):195-205. PubMed ID: 26941580
    [Abstract] [Full Text] [Related]

  • 34. Three plasma-based microRNAs as potent diagnostic biomarkers for endometrial cancer.
    Fan X, Cao M, Liu C, Zhang C, Li C, Cheng W, Zhang S, Zhang H, Zhu W.
    Cancer Biomark; 2021 Dec 14; 31(2):127-138. PubMed ID: 33896823
    [Abstract] [Full Text] [Related]

  • 35. Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.
    Huang Z, Zhu D, Wu L, He M, Zhou X, Zhang L, Zhang H, Wang W, Zhu J, Cheng W, Chen Y, Fan Y, Qi L, Yin Y, Zhu W, Shu Y, Liu P.
    Cancer Epidemiol Biomarkers Prev; 2017 Feb 14; 26(2):188-196. PubMed ID: 27756776
    [Abstract] [Full Text] [Related]

  • 36. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB, Barták BK, Kalmár A, Galamb O, Wichmann B, Dank M, Igaz P, Tulassay Z, Molnár B.
    Pathol Oncol Res; 2019 Jan 14; 25(1):97-105. PubMed ID: 28980150
    [Abstract] [Full Text] [Related]

  • 37. Differential expression levels of plasma microRNA in Hashimoto's disease.
    Zhao L, Zhou X, Shan X, Qi LW, Wang T, Zhu J, Zhu D, Huang Z, Zhang L, Zhang H, Yin Y, Wang Z, Zhu W, Cheng W, Jiang L.
    Gene; 2018 Feb 05; 642():152-158. PubMed ID: 29054761
    [Abstract] [Full Text] [Related]

  • 38. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
    Wang L, Lin J, Yu T, Zuo Q, Shen B, Zhang H, Liu B, Cai D, Mao H, Zhao H, Zou Q, Xiao B.
    Clin Biochem; 2020 Oct 05; 84():79-86. PubMed ID: 32673627
    [Abstract] [Full Text] [Related]

  • 39. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.
    Zhang L, Zhang Y, Xue S, Ding H, Wang Y, Qi H, Wang Y, Zhu W, Li P.
    J Cell Mol Med; 2020 Jan 05; 24(1):1146-1150. PubMed ID: 31709737
    [Abstract] [Full Text] [Related]

  • 40. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.